This article first appeared on GuruFocus.
After a Rome court ruled that Netflix (NFLX, Financials) raised subscription prices from 2017 to 2024 in violation of consumer protection laws, the company is at greater legal risk in Italy.
The court said that Netflix's contract terms didn't clearly explain why those prices went up. The decision could mean that millions of current and former users get their money back.
The court also told Netflix to lower prices for users who were affected. The price of a premium plan could go down from 19.99 to 11.99, and the price of a standard plan could go down from 13.99 to 9.99.
Lawyers for the consumer group said premium users who had been paying since 2017 could get back up to 500. Users of the standard plan could get about 250.
The court also told Netflix to tell affected users, including former subscribers, and to post the decision on its website and in the national press.
Netflix has said that it thinks its terms were in line with Italian law and plans to appeal. The company hasn't responded to the latest order to lower prices.
LATEST POSTS
- 1
Defence chiefs of Thailand and Cambodia to discuss ceasefire - 2
A top Marine shares his secrets to keeping fit at 50 - 3
Instructions to Keep up with Your Traded Teeth for Life span - 4
Consume Fat Quick: 10 Demonstrated Activities for Ideal Outcomes - 5
IDF carried out mission to locate former hostage Avera Mengistu a day before Oct. 7
FDA claims on COVID-19 vaccine safety are unsupported by reliable data – and could severely hinder vaccine access
Mickey Lee of 'Big Brother' fame dead at 35 after flu complications, family says
Burkina Faso must 'forget' about democracy, military leader says
NASA's Perseverance Mars rover could break the record for miles driven on another planet
Vote In favor of Your Favored Keeping an eye on
Massive supernova explosion may have created a binary black hole
The Electric Bicycle Americans Can Confide in 2024
The 15 Best Business visionaries Under 40
Novo Nordisk slashes prices of popular weight loss and diabetes drugs













